Immediate_JJ
early_JJ
and_CC
early_JJ
lytic_JJ
cycle_NN
proteins_NNS
are_VBP
frequent_JJ
targets_NNS
of_IN
the_DT
Epstein-Barr_JJ
virus-induced_JJ
cytotoxic_JJ
T_NN
cell_NN
response_NN
._.

Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
,_,
a_DT
human_JJ
gamma-herpesvirus_NN
,_,
can_MD
establish_VB
both_CC
nonproductive_JJ
-LRB-_-LRB-
latent_JJ
-RRB-_-RRB-
and_CC
productive_JJ
-LRB-_-LRB-
lytic_JJ
-RRB-_-RRB-
infections_NNS
._.

Although_IN
the_DT
CD8_NN
+_CC
cytotoxic_JJ
T_NN
lymphocyte_NN
-LRB-_-LRB-
CTL_NN
-RRB-_-RRB-
response_NN
to_TO
latently_RB
infected_VBN
cells_NNS
is_VBZ
well_RB
characterized_VBN
,_,
very_RB
little_JJ
is_VBZ
known_VBN
about_IN
T_NN
cell_NN
controls_NNS
over_IN
lytic_JJ
infection_NN
;_:
this_DT
imbalance_NN
in_IN
our_PRP$
understanding_NN
belies_VBZ
the_DT
importance_NN
of_IN
virus-replicative_JJ
lesions_NNS
in_IN
several_JJ
aspects_NNS
of_IN
EBV_NN
disease_NN
pathogenesis_NN
._.

The_DT
present_JJ
work_NN
shows_VBZ
that_IN
the_DT
primary_JJ
CD8_NN
+_CC
CTL_NN
response_NN
to_TO
EBV_NN
in_IN
infectious_JJ
mononucleosis_NN
patients_NNS
contains_VBZ
multiple_JJ
lytic_JJ
antigen-specific_JJ
reactivities_NNS
at_IN
levels_NNS
at_IN
least_JJS
as_IN
high_JJ
as_IN
those_DT
seen_VBN
against_IN
latent_JJ
antigens_NNS
;_:
similar_JJ
reactivities_NNS
are_VBP
also_RB
detectable_JJ
in_IN
CTL_NN
memory_NN
._.

Clonal_JJ
analysis_NN
revealed_VBD
individual_JJ
responses_NNS
to_TO
the_DT
two_CD
immediate_JJ
early_JJ
proteins_NNS
BZLF1_NN
and_CC
BRLF1_NN
,_,
and_CC
to_TO
three_CD
-LRB-_-LRB-
BMLF1_NN
,_,
BMRF1_NN
,_,
and_CC
BALF2_NN
-RRB-_-RRB-
of_IN
the_DT
six_CD
early_JJ
proteins_NNS
tested_VBD
._.

In_IN
several_JJ
cases_NNS
,_,
the_DT
peptide_NN
epitope_NN
and_CC
HLA-restricting_JJ
determinant_NN
recognized_VBN
by_IN
these_DT
CTLs_NNS
has_VBZ
been_VBN
defined_VBN
,_,
one_CD
unusual_JJ
feature_NN
being_VBG
the_DT
number_NN
of_IN
responses_NNS
restricted_JJ
through_IN
HLA-C_NN
alleles_NNS
._.

The_DT
work_NN
strongly_RB
suggests_VBZ
that_IN
EBV-replicative_JJ
lesions_NNS
are_VBP
subject_JJ
to_TO
direct_VB
CTL_NN
control_NN
in_FW
vivo_FW
and_CC
that_IN
immediate_JJ
early_JJ
and_CC
early_JJ
proteins_NNS
are_VBP
frequently_RB
the_DT
immunodominant_JJ
targets_NNS
._.

This_DT
contrasts_VBZ
with_IN
findings_NNS
in_IN
alpha_NN
-_:
and_CC
beta-herpesvirus_NN
systems_NNS
-LRB-_-LRB-
herpes_NN
simplex_NN
,_,
cytomegalovirus_NN
-RRB-_-RRB-
where_WRB
viral_JJ
interference_NN
with_IN
the_DT
antigen-processing_JJ
pathway_NN
during_IN
lytic_JJ
infection_NN
renders_VBZ
immediate_JJ
early_JJ
and_CC
early_JJ
proteins_NNS
much_RB
less_JJR
immunogenic_JJ
._.

The_DT
unique_JJ
capacity_NN
of_IN
gamma-herpesvirus_NN
to_TO
amplify_VB
the_DT
viral_JJ
load_NN
in_FW
vivo_FW
through_IN
a_DT
latent_JJ
growth-transforming_JJ
infection_NN
may_MD
have_VB
rendered_VBN
these_DT
agents_NNS
less_RBR
dependent_JJ
upon_IN
viral_JJ
replication_NN
as_IN
a_DT
means_NN
of_IN
successfully_RB
colonizing_VBG
their_PRP$
hosts_NNS
._.

